Tag: COVID-19

  • Current Status & Trajectory of COVID

    Key Points: In today’s Recommendation for Industry, we discuss the continued westward movement of COVID in the U.S. Read more below. BA.4/5 COVID-19 variants now dominant in all US regions. Combined, the two subvariants make up more than 70% of recently sequenced samples, up sharply from 52.3% the previous week. Of the variants CDC is…

  • TAG Recommendations for COVID and Monkeypox

    Key Points: In today’s Recommendation for Industry, we provide current updates and recommendations on COVID and Monkeypox transmission. Read more below. COVID vaccines prevented poor outcomes in people of all sizes. COVID-19 vaccination protected people of all body sizes from hospitalization and death—although vaccinated people with a low or high body mass index (BMI) were…

  • COVID Westward Migration Continues

    Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read more below. FDA advisory committee is recommending Omicron variant to be within COVID boosters. The proportion of BA.4 and BA.5 increased in the week ending June 25th, mainly due to…

  • COVID-19 & Monkeypox Updates

    Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response. A modified booster shot targeting Omicron specifically increased neutralizing antibody levels 13.5 to 19.6 times higher than the current shot. A booster targeting both Omicron and the original virus increased…

  • COVID: Progressive Trajectories Very Encouraging

    Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women more likely to have long COVID, different symptom profile. For the shorter-term COVID, females were more likely than males to experience issues related to mood; ear, nose, and throat; musculoskeletal;…

  • Monkeypox: Steps Businesses Can Take to Keep Risk Low

    Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it low. Read more below. Omicron is as much as 50% less likely to lead to long COVID, study finds. The numbers of individuals that were infected with Omicron were more…

  • COVID Trends Continue, but Severity Remains Low

    Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna COVID vaccine for kids 6 to 17. Previously only Pfizer was approved for ages 5-17 and the CDC had recommended that age range receive a single-dose booster. The CDC reports…

  • Monkeypox: What It Is and How It Spreads

    Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by 1 year. Infants born to mothers infected with SARS-CoV-2 during pregnancy were more likely to receive a neurodevelopmental diagnosis by 1 year of age, regardless of whether they were born…

  • COVID U.S.: Surge Moving Westward; BA.4 and BA.5 Increasing

    Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read more below. Reporting Home COVID Test Results Can Be Confusing. Here’s How to Do It. The Centers for Disease Control and Prevention “strongly encourages” everyone who self-tests to report their…

  • Defending Against Infectious Disease

    Key Points: In today’s Recommendation for Industry, we discuss defending against infectious disease. Read more below. COVID-19 vaccine during pregnancy may protect infants. The COVID-19 vaccination has shown through a study performed by JAMA Internal Medicine that it can protect babies for their first 4 months of life. Protection for infants was 33% during the…